By the time most people think about bone health, the window to build strong bones has already closed. Peak bone mass is largely set by the late twenties, and the foundation is poured during childhood and adolescence. New research suggests that PFAS, the synthetic “forever chemicals” found in drinking water, nonstick cookware, and food packaging, may be undermining that foundation during the very years it matters most.
A peer-reviewed study published in the Journal of the Endocrine Society examined how the timing of exposure to per- and polyfluoroalkyl substances during early life relates to bone mineral density in teenagers. The researchers found that PFOA, one of the most widely studied PFAS compounds, was associated with lower bone mineral density in adolescents, with effects that varied depending on when exposure occurred, according to PubMed records for the study. Other PFAS compounds showed different patterns, reinforcing that this sprawling chemical family, which the EPA estimates includes more than 14,000 identified structures, does not act uniformly on the body.
What the research found
The study analyzed PFAS exposure across multiple early-life windows and measured bone outcomes using dual-energy X-ray absorptiometry (DXA), the clinical standard for assessing bone density. Its central finding was that PFOA exposure during specific developmental periods was tied to measurably lower bone mineral density in teens. Because bones grow most rapidly during infancy and puberty, disruptions in those windows could reduce peak bone mass, the maximum density a person achieves before age-related bone loss begins. Lower peak bone mass is a well-established risk factor for osteoporosis and fractures later in life.
The research builds on a larger, separate analysis that drew from the National Health and Nutrition Examination Survey, the federal government’s primary biomonitoring program. That earlier study, published in the Journal of Exposure Science and Environmental Epidemiology, analyzed a sample of 6,416 participants using NHANES data collected between 2005 and 2014. It measured serum PFAS concentrations alongside DXA-derived bone density and reported differences in how PFAS exposure related to bone outcomes between males and females. It is worth noting that NHANES has released more recent PFAS biomonitoring cycles, including 2017 to 2018 data, which could update the exposure picture; however, the studies discussed here did not incorporate those newer cycles.
Both studies relied on data collected through the NHANES program, which is maintained by the CDC’s National Center for Health Statistics. NHANES uses standardized blood sampling and DXA scanning protocols, and its data are publicly available, allowing independent researchers to verify exposure measurements and bone density outcomes. That open framework gives studies built on it a credibility advantage over research using proprietary or smaller datasets.
Why timing matters
The adolescent-focused study’s most notable contribution is its attention to exposure windows. Rather than treating PFAS exposure as a single, static measurement, the researchers attempted to reconstruct when during early life children encountered these chemicals and whether certain periods carried greater skeletal risk.
This matters because bone biology is not constant. During infancy, the skeleton is rapidly mineralizing. During puberty, hormonal surges drive a second major phase of bone accrual. If PFOA interferes with bone-building processes more potently during one of these windows than another, that narrows the biological question and could eventually shape when interventions or exposure reductions would have the greatest protective effect.
The finding that different PFAS compounds showed different timing-dependent associations also carries practical implications. Regulatory and public health responses that treat all PFAS identically may overlook the fact that specific chemicals like PFOA appear to carry greater bone-related risks at particular life stages. This distinction could influence which compounds receive priority attention in future drinking water standards or product safety rules.
Important limitations
Neither study tracked participants over time into adulthood. Both relied on cross-sectional survey data, capturing PFAS levels and bone density at a single point rather than following the same children as they aged. This design can identify associations but cannot prove that PFAS exposure directly caused the observed differences. Diet, physical activity, genetics, hormonal status, and co-occurring environmental exposures like lead or cadmium all influence bone density and were not fully accounted for in every analysis.
There is also a measurement challenge. Serum PFAS levels drawn at one time point may not perfectly reflect cumulative exposure during earlier, potentially more vulnerable periods such as pregnancy or infancy. While PFAS are famously persistent in the body, with half-lives measured in years, concentrations can still shift as water sources, consumer products, and behaviors change. The adolescent-focused study attempted to reconstruct earlier exposure windows, but without repeated blood draws over a child’s lifetime, some misclassification is inevitable.
The supplemental data tables for the newer study, including detailed effect estimates, confidence intervals, and the specific DXA measurement sites analyzed, are expected to be available through the Journal of the Endocrine Society’s publisher platform but have not been independently reviewed for this article.
The regulatory landscape
These bone-health findings arrive at a moment when PFAS regulation in the United States is already shifting. In April 2024, the EPA finalized the first-ever enforceable national drinking water limits for six PFAS compounds, setting maximum contaminant levels for PFOA and PFOS at 4 parts per trillion each. Those limits were driven primarily by evidence linking PFAS to cancer, cardiovascular disease, and immune suppression. Bone health was not a central factor in that rulemaking.
Whether skeletal effects will be incorporated into future regulatory risk assessments remains an open question. No institutional statements from the CDC or EPA responding to these specific bone density findings have been issued as of May 2026. The National Academies of Sciences, Engineering, and Medicine released a 2022 report recommending clinical guidance for PFAS-exposed populations, and the American Academy of Pediatrics has urged clinicians to counsel families on reducing PFAS exposure, but neither body has issued bone-specific recommendations tied to this research.
CDC biomonitoring data show that PFAS are detectable in the blood of nearly all Americans tested, meaning the population potentially affected by even modest bone effects is enormous. If future longitudinal studies confirm a causal link between early PFAS exposure and reduced peak bone mass, the public health implications would extend well beyond childhood, potentially contributing to higher rates of osteoporosis and fractures in aging populations decades from now.
What families can do now
These studies do not yet support specific clinical recommendations tied directly to PFAS blood levels, and no medical guidelines have changed as a result of this research. But the findings do reinforce a practical case for reducing unnecessary PFAS exposure where possible.
Families living in areas with known PFAS water contamination can check local water quality reports, often available through their utility or the EPA’s online tools, and consider NSF-certified filtration systems (reverse osmosis or activated carbon filters rated for PFAS reduction). Avoiding food packaging and cookware marketed as stain- or grease-resistant can also reduce household exposure, though eliminating PFAS entirely is not realistic given their prevalence.
For bone health specifically, the most evidence-backed approach remains ensuring children get adequate calcium, vitamin D, and regular weight-bearing physical activity. These factors have decades of research supporting their role in building peak bone mass, and they remain protective regardless of chemical exposure status.
Where mixture research and longitudinal tracking go from here
The broader scientific question, whether real-world mixtures of multiple PFAS compounds acting together amplify or dampen the effects seen for individual chemicals, is only partially addressed by the available work. Future research that explicitly models these mixtures, follows children into adulthood with repeated measurements, and incorporates detailed data on diet, activity, and co-exposures will be needed to move from association toward a clearer understanding of cause and effect. For now, two independent analyses using robust national data point in the same direction: PFAS, and especially PFOA, are associated with weaker bones during the years when the skeleton should be at its strongest.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
